AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 162 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,218,000 | -21.3% | 562,350 | -4.6% | 0.48% | -9.5% |
| Q1 2022 | $5,362,000 | -0.3% | 589,200 | -21.4% | 0.53% | +47.8% |
| Q4 2021 | $5,378,000 | -37.1% | 750,000 | 0.0% | 0.36% | -40.3% |
| Q3 2021 | $8,550,000 | -28.8% | 750,000 | 0.0% | 0.60% | -26.4% |
| Q2 2021 | $12,008,000 | -10.4% | 750,000 | 0.0% | 0.82% | -12.8% |
| Q1 2021 | $13,403,000 | +16.7% | 750,000 | -11.8% | 0.94% | -0.2% |
| Q4 2020 | $11,484,000 | +14.8% | 850,000 | 0.0% | 0.94% | +5.3% |
| Q3 2020 | $10,005,000 | +14.9% | 850,000 | +44.1% | 0.89% | -5.4% |
| Q2 2020 | $8,708,000 | -10.4% | 590,000 | -18.1% | 0.94% | -30.9% |
| Q1 2020 | $9,720,000 | -42.5% | 720,000 | +2.9% | 1.36% | -26.5% |
| Q4 2019 | $16,919,000 | +85.3% | 700,000 | +47.4% | 1.85% | +61.9% |
| Q3 2019 | $9,130,000 | +18.8% | 475,000 | +82.7% | 1.14% | +35.3% |
| Q2 2019 | $7,683,000 | -37.8% | 260,000 | 0.0% | 0.85% | -41.5% |
| Q1 2019 | $12,350,000 | +22.2% | 260,000 | -7.1% | 1.44% | +25.1% |
| Q4 2018 | $10,108,000 | -8.8% | 280,000 | +55.6% | 1.16% | +4.1% |
| Q3 2018 | $11,079,000 | +134.3% | 180,000 | +157.1% | 1.11% | +129.3% |
| Q2 2018 | $4,729,000 | +117.9% | 70,000 | +75.0% | 0.48% | +81.3% |
| Q1 2018 | $2,170,000 | -71.4% | 40,000 | -68.5% | 0.27% | -73.9% |
| Q4 2017 | $7,578,000 | +28.9% | 126,829 | +4.9% | 1.02% | +36.5% |
| Q3 2017 | $5,877,000 | +49.1% | 120,932 | +61.2% | 0.75% | +32.5% |
| Q2 2017 | $3,941,000 | +2.2% | 75,000 | -11.8% | 0.57% | -7.2% |
| Q1 2017 | $3,855,000 | +190.9% | 85,000 | +142.9% | 0.61% | +140.2% |
| Q4 2016 | $1,325,000 | – | 35,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |